InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: dr_lowenstein post# 312443

Saturday, 03/23/2019 11:26:29 PM

Saturday, March 23, 2019 11:26:29 PM

Post# of 402256

lol lol I never suggested there was no futility analysis







Thanks for letting us know. Did someone say you did? I would not want that because it would be incorrect to suggest there was no futility analysis.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147754858

Not only did the study pass through the futility checkpoint, that checkpoint was complete 3 year data on 168 patients. Many full studies aren't even that big. The study was designed to detect if there was at least 25% slowing of functional decline with isradipine, and it would have been stopped if it didn't look like it was happening after 50% of participants had completed the study.






Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News